| Followers | 2559 |
| Posts | 59363 |
| Boards Moderated | 0 |
| Alias Born | 06/04/2004 |
Wednesday, August 05, 2020 7:35:19 AM
I THINK BOTTOM IS IN, IM GOOD FOR ANOTHER 30-40K SHARES AGAIN TODAY. I CAUTION AGAINST ALLOWING YESTERDAYS, THE DAY BEFORE, OR TOMORROWS PPS DISCOURAGING YOU FROM HANGING IN HERE...
NO MATTER WHAT ELSE HAPPENS, IMO WE ARE THE FRONT RUNNER AS FAR AS COVID 19 THERAPEUTICS BEING TESTED AT PHASE 3. CURRENTLY THERE ARE NO OFFICIAL THERAPEUTICS APPROVED.
RVVTF HOPES TO BE THE FIRST WITH BUCILLAMINE.
WE GET THERE
NO MATTER WHAT ELSE HAPPENS, IMO WE ARE THE FRONT RUNNER AS FAR AS COVID 19 THERAPEUTICS BEING TESTED AT PHASE 3. CURRENTLY THERE ARE NO OFFICIAL THERAPEUTICS APPROVED.
RVVTF HOPES TO BE THE FIRST WITH BUCILLAMINE.
WE GET THERE
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM

